Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	190.40	56.36	19.41
Graham Fair Price	-53.74	1385.03	2993.84
PEG	230.64	0.16	0.05
Price/Book	-2.76	0.47	0.48
Price/Cash Flow	-51.93	11.73	-24.40
Prices/Earnings	349.39	-18.90	4.21
Price/Sales	8.53	0.56	0.51
Price/FCF	-51.93	11.73	-24.40
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-52.07	0.04	0.08
Operating Margin	-84.83	< 0.005	0.05
ROA	-79.38	< 0.005	0.01
ROE	0.03	< 0.005	-78.36
ROIC	0.02	< 0.005	-87.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.12	-0.05	163.75
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.27	-0.86	221.92
EPS QOQ	0.89	-1.22	35.92
FCF QOQ	0.59	3.01	409.38
Revenue QOQ	0.15	-0.11	-27.32
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	59.53	70.36	18.19
Days Sales Outstanding (DSO)	35.15	35.67	1.48
Inventory Turnover	1.51	1.28	-15.39
Debt/Capitalization	0.50	0.53	5.90
Quick Ratio	0.44	0.42	-4.88
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3738.23	3717.79	-0.55
Cash	400.42	744.08	85.83
Capex	-178.98	-74.32	58.48
Free Cash Flow	-73.47	147.82	101.20
Revenue	3484.97	3105.36	-10.89
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.98	0.92	-5.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.56	37.25	196.57
Naive Interpretation	Member

06 - Financial Health · Bad

Rating